Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
C 5.41 0.19% 0.01
TLC closed up 0.19 percent on Friday, February 26, 2021, on 54 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical TLC trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Fell Below 20 DMA Bearish 0.19%
1,2,3 Pullback Bullish Bullish Swing Setup 0.19%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.19%
1,2,3 Pullback Bullish Bullish Swing Setup -5.58%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.58%
Inside Day Range Contraction -5.58%
MACD Bearish Signal Line Cross Bearish -3.74%
Overbought Stochastic Strength -3.74%
Older End-of-Day Signals for TLC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance 5 days ago
1.5x Volume Pace 5 days ago
Down 5% 5 days ago
Down 3% 5 days ago
Down 2 % 5 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taiwan Liposome Company, Ltd. Description

Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Drugs Pharmaceutical Products Inflammation Pharmacology Ophthalmic Ophthalmology Drug Delivery Lipid Icos Macular Edema Arthritis Bupivacaine Drug Delivery System Corticosteroid Doxorubicin Fungal Infection Local Anesthetic Arbutus Biopharma Liposome Peripheral Arterial Disease Treatment Of Inflammation Amphotericin B

Is TLC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.65
52 Week Low 2.48
Average Volume 27,511
200-Day Moving Average 5.01
50-Day Moving Average 4.96
20-Day Moving Average 5.55
10-Day Moving Average 5.68
Average True Range 0.27
ADX 30.3
+DI 17.53
-DI 17.76
Chandelier Exit (Long, 3 ATRs ) 5.06
Chandelier Exit (Short, 3 ATRs ) 5.46
Upper Bollinger Band 6.03
Lower Bollinger Band 5.07
Percent B (%b) 0.35
BandWidth 17.42
MACD Line 0.19
MACD Signal Line 0.24
MACD Histogram -0.0584
Fundamentals Value
Market Cap 227.64 Million
Num Shares 42.1 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -10.69
Price-to-Sales 50.63
Price-to-Book 7.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.65
Resistance 3 (R3) 5.65 5.58 5.61
Resistance 2 (R2) 5.58 5.52 5.58 5.60
Resistance 1 (R1) 5.49 5.48 5.46 5.49 5.58
Pivot Point 5.42 5.42 5.40 5.42 5.42
Support 1 (S1) 5.33 5.36 5.30 5.33 5.24
Support 2 (S2) 5.26 5.32 5.26 5.22
Support 3 (S3) 5.17 5.26 5.21
Support 4 (S4) 5.17